Nanostring technologies, INC.:1165300 [23-002118]
Ended Awarded Last action
- Contract number
- 75N92B23F00001
- Awardee
-
Nanostring Technologies, Inc. UEI JEKKWSBFM2K4
- Awarding agency
-
National Insititue of Arthritis and Musculoskeletal and Skin Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $24,900
Award facts
- Contract value 100% obligated
- $24,900.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 339999 All Other Miscellaneous Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Seattle, WA 98119, USA
Award details come from SAM.gov/FPDS.
About this award
Nanostring Technologies, Inc. received a contract award valued at $24,900 from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) on August 21, 2014, with completion by August 31, 2023. This firm fixed-price Blanket Purchase Agreement (BPA) call, with no set-aside designation, was performed in Seattle, Washington. Nanostring is a publicly traded provider of advanced genomic analysis platforms and life science tools, specializing in multiplexed digital detection technologies such as the nCounter Analysis Systems and GeoMx Digital Spatial Profiler. The company supplies specialized laboratory equipment, reagents, assays, and testing services to support biomedical research across federal agencies.
Under this award, NIAMS procured genomic analysis products and services from Nanostring to support the institute's research mission in arthritis, musculoskeletal diseases, and skin disorders. This contract represents a typical procurement in the $10,000–$25,000 range for reagents and consumables that Nanostring regularly delivers to NIH institutes. The award aligns with NIAMS's broader research initiatives and reflects the agency's reliance on Nanostring's proprietary molecular analysis platforms to advance translational research and understanding of complex musculoskeletal and dermatological conditions.
Quick answers
Who was awarded contract 75N92B23F00001?
75N92B23F00001 was awarded to Nanostring Technologies, Inc. by National Insititue of Arthritis and Musculoskeletal and Skin Diseases (National Institutes of Health) on August 21, 2014.
How much is contract 75N92B23F00001 worth?
The government has obligated $24,900 on 75N92B23F00001.
Is contract 75N92B23F00001 an order under another contract?
Yes. 75N92B23F00001 is a BPA call under HHSN263201400050B, a blanket purchase agreement.
Was contract 75N92B23F00001 competed?
The extent of competition for 75N92B23F00001 was competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award